Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Pharma Industry Analysis

UpdatedMay 23, 2025
DataAggregated Company Financials
Companies41
  • 7D3.5%
  • 3M-0.4%
  • 1Y1.0%
  • YTD-3.3%

The Pharma industry is up 3.5% in the last week, with Daiichi Sankyo Company up 12%. Overall in the last year, the industry is flat. Looking forward, earnings are forecast to grow by 9.2% annually.

Industry Valuation and Performance

Has the Japanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 23 May 2025JP¥40.1tJP¥16.8tJP¥1.8t14.4x22.7x2.4x
Sun, 20 Apr 2025JP¥40.5tJP¥16.5tJP¥1.5t14.5x26.9x2.5x
Tue, 18 Mar 2025JP¥40.1tJP¥16.5tJP¥1.5t16x26.7x2.4x
Thu, 13 Feb 2025JP¥39.4tJP¥16.4tJP¥1.3t15.1x30.1x2.4x
Sat, 11 Jan 2025JP¥40.8tJP¥16.1tJP¥1.4t16.2x28.9x2.5x
Mon, 09 Dec 2024JP¥42.6tJP¥16.1tJP¥1.4t15.1x30.2x2.7x
Wed, 06 Nov 2024JP¥44.8tJP¥16.0tJP¥1.4t15.9x32x2.8x
Fri, 04 Oct 2024JP¥44.1tJP¥15.5tJP¥1.2t15.9x36.7x2.8x
Sun, 01 Sep 2024JP¥48.4tJP¥15.5tJP¥1.2t18x40.3x3.1x
Tue, 30 Jul 2024JP¥45.3tJP¥15.1tJP¥1.1t18.5x40.3x3x
Thu, 27 Jun 2024JP¥42.8tJP¥15.0tJP¥1.1t18x39.1x2.8x
Sat, 25 May 2024JP¥40.3tJP¥15.0tJP¥1.1t16.5x36.8x2.7x
Mon, 22 Apr 2024JP¥38.7tJP¥14.8tJP¥1.2t18.2x32x2.6x
Wed, 20 Mar 2024JP¥43.3tJP¥15.1tJP¥1.2t19.8x35.7x2.9x
Fri, 16 Feb 2024JP¥41.5tJP¥15.1tJP¥1.3t20.2x32.5x2.8x
Sun, 14 Jan 2024JP¥42.3tJP¥15.2tJP¥1.4t20.3x30.7x2.8x
Tue, 12 Dec 2023JP¥40.0tJP¥15.2tJP¥1.4t20x29.1x2.6x
Thu, 09 Nov 2023JP¥38.9tJP¥15.1tJP¥1.4t22.7x28.2x2.6x
Sat, 07 Oct 2023JP¥39.1tJP¥14.9tJP¥1.4t23.1x27.3x2.6x
Mon, 04 Sep 2023JP¥40.6tJP¥14.9tJP¥1.4t23.5x28.4x2.7x
Wed, 02 Aug 2023JP¥40.1tJP¥14.9tJP¥1.4t21.9x28x2.7x
Fri, 30 Jun 2023JP¥40.5tJP¥14.6tJP¥1.5t20.7x27.7x2.8x
Sun, 28 May 2023JP¥39.7tJP¥14.6tJP¥1.5t19.6x27.1x2.7x
Tue, 25 Apr 2023JP¥38.6tJP¥14.3tJP¥1.5t18x26.3x2.7x
Thu, 23 Mar 2023JP¥37.0tJP¥14.3tJP¥1.5t16.4x25.2x2.6x
Sat, 18 Feb 2023JP¥37.0tJP¥14.3tJP¥1.5t17.3x25.2x2.6x
Mon, 16 Jan 2023JP¥36.1tJP¥13.7tJP¥1.4t19x26.7x2.6x
Wed, 14 Dec 2022JP¥39.6tJP¥13.7tJP¥1.3t18.7x29.3x2.9x
Fri, 11 Nov 2022JP¥38.3tJP¥13.6tJP¥1.3t17.5x28.5x2.8x
Sun, 09 Oct 2022JP¥38.2tJP¥13.3tJP¥1.4t18x26.7x2.9x
Tue, 06 Sep 2022JP¥36.5tJP¥13.3tJP¥1.4t17.5x25.5x2.7x
Thu, 04 Aug 2022JP¥35.0tJP¥13.3tJP¥1.4t17.4x24.3x2.6x
Sat, 02 Jul 2022JP¥35.3tJP¥13.1tJP¥1.5t17.8x24.1x2.7x
Mon, 30 May 2022JP¥34.5tJP¥13.1tJP¥1.5t17.8x23.6x2.6x
Price to Earnings Ratio

23.6x


Total Market Cap: JP¥34.5tTotal Earnings: JP¥1.5tTotal Revenue: JP¥13.1tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Pharma Industry Price to Earnings3Y Average 29.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Japanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 22.7x which is lower than its 3-year average PE of 29.5x.
  • The 3-year average PS ratio of 2.7x is higher than the industry's current PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 6.5% per year over the last three years.
  • Revenues for these companies have grown 8.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-0.75%
Healthcare1.76%
Pharma3.52%
Pharma3.52%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4568 Daiichi Sankyo CompanyJP¥3.74k8.3%
+JP¥535.7b		-31.3%PE23.6x
4502 Takeda PharmaceuticalJP¥4.16k2.0%
+JP¥126.5b		0.6%PE60.2x
4507 ShionogiJP¥2.33k4.9%
+JP¥91.9b		0.9%PE11.6x
4503 Astellas PharmaJP¥1.39k2.0%
+JP¥48.3b		-11.0%PE49.1x
4519 Chugai PharmaceuticalJP¥7.55k0.4%
+JP¥44.4b		59.1%PE30.3x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4568

JP¥3,741.00

Daiichi Sankyo Company

7D

8.3%

1Y

-31.3%

4503

JP¥1,393.00

Astellas Pharma

7D

2.0%

1Y

-11.0%

4523

JP¥3,881.00

Eisai

7D

4.0%

1Y

-42.6%

4548

JP¥640.00

Seikagaku

7D

-2.3%

1Y

-17.6%

Earnings Troubles May Signal Larger Issues for Seikagaku (TSE:4548) Shareholders

May 22
Earnings Troubles May Signal Larger Issues for Seikagaku (TSE:4548) Shareholders

4886

JP¥2,349.00

ASKA Pharmaceutical HoldingsLtd

7D

-1.0%

1Y

3.1%

Weak Statutory Earnings May Not Tell The Whole Story For ASKA Pharmaceutical HoldingsLtd (TSE:4886)

May 21
Weak Statutory Earnings May Not Tell The Whole Story For ASKA Pharmaceutical HoldingsLtd (TSE:4886)

4519

JP¥7,554.00

Chugai Pharmaceutical

7D

0.4%

1Y

59.1%

Chugai Pharmaceutical (TSE:4519) Is Paying Out A Larger Dividend Than Last Year

May 21
Chugai Pharmaceutical (TSE:4519) Is Paying Out A Larger Dividend Than Last Year

4506

JP¥782.00

Sumitomo Pharma

7D

-6.1%

1Y

160.7%

We Believe Sumitomo Pharma's (TSE:4506) Earnings Are A Poor Guide For Its Profitability

May 20
We Believe Sumitomo Pharma's (TSE:4506) Earnings Are A Poor Guide For Its Profitability

4540

JP¥3,500.00

Tsumura

7D

-3.2%

1Y

-9.5%

4887

JP¥1,892.00

Sawai Group Holdings

7D

6.8%

1Y

-2.6%

4507

JP¥2,328.00

Shionogi

7D

4.9%

1Y

0.9%

4151

JP¥2,202.50

Kyowa Kirin

7D

-0.4%

1Y

-14.2%

Kyowa Kirin (TSE:4151) Will Pay A Larger Dividend Than Last Year At ¥30.00

May 15
Kyowa Kirin (TSE:4151) Will Pay A Larger Dividend Than Last Year At ¥30.00

4502

JP¥4,159.00

Takeda Pharmaceutical

7D

2.0%

1Y

0.6%

4528

JP¥1,542.00

Ono Pharmaceutical

7D

1.7%

1Y

-31.3%

Earnings Miss: Ono Pharmaceutical Co., Ltd. Missed EPS By 12% And Analysts Are Revising Their Forecasts

May 11
Earnings Miss: Ono Pharmaceutical Co., Ltd. Missed EPS By 12% And Analysts Are Revising Their Forecasts

4565

JP¥819.00

Nxera Pharma

7D

-0.4%

1Y

-42.1%

4530

JP¥4,149.00

Hisamitsu Pharmaceutical

7D

-1.0%

1Y

11.1%

4896

JP¥710.00

K PharmaInc

7D

-4.3%

1Y

14.5%